Masahide Takahashi
Osaka Prefecture University*
Sakai, 5998531, Japan
Sakai, 5998531, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 143 publications
First-in-human phase I study of hypoxia-targeting 64Cu-ATSM radioligand therapy in patients with malignant brain tumors (STAR-64).
Journal: ESMO open
Published: January 04, 2026
Response to comment on "Four decades of the RET gene: From discovery to tumor-agnostic therapy".
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: August 15, 2025
Local, but not circulating, complement C3 shapes immune checkpoint blockade efficacy by controlling myeloid cell infiltration.
Journal: Nature communications
Published: May 28, 2025
Four decades of the RET gene: From discovery to tumor-agnostic therapy.
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: May 19, 2025
Meflin is a druggable target using antibody-drug conjugates in progressive osteosarcoma.
Journal: Oncogene
Published: March 31, 2025
Solvato/Vapochromism-Based Alcohol Sensing through Metal-Organic Framework Thin Films with Coordinatively Unsaturated Metal Sites.
Journal: Small science
Published: December 19, 2024
Machine learning-assisted chemical design of highly efficient deicers.
Journal: Scientific reports
Published: January 30, 2024
Synthetic retinoid-mediated preconditioning of cancer-associated fibroblasts and macrophages improves cancer response to immune checkpoint blockade.
Journal: British journal of cancer
Published: November 29, 2023
CD109 Attenuates Bleomycin-induced Pulmonary Fibrosis by Inhibiting TGF-β Signaling.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: April 25, 2023
Last Updated: 09/26/2026